ATC Group: R03CC03 Terbutaline

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R03CC03 in the ATC hierarchy

Level	Code	Title
`1`	R	Respiratory system
`2`	R03	Drugs for obstructive airway diseases
`3`	R03C	Adrenergics for systemic use
`4`	R03CC	Selective beta-2-adrenoreceptor agonists
`5`	R03CC03	Terbutaline

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	15 mg
PAREN	Parenteral	15 mg

Active ingredients in R03CC03

Active Ingredient
Terbutaline
Terbutaline is a selective beta₂-adrenoceptor agonist, thus producing relaxation of bronchial smooth muscle, inhibition of the release of endogenous spasmogens, inhibitions of oedema caused by endogenous mediators, increased mucociliary clearance and relaxation of the uterine muscle.

Related product monographs

Document	Type	Information Source
ATALINE Syrup	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
ATALINE Tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
BRICANYL Solution for injection or infusion	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
BRICANYL Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
BRICANYL TURBOHALER Inhalation powder	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)